InDDEx

InDDEx

Neurology A clinical trial–Investigation into Delay to Diagnosis of Alzheimer's disease with Exelon. See Alzheimer's disease.
Mentioned in ?
References in periodicals archive ?
Winblad et al., "Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study," The Lancet Neurology, vol.
En estos momentos contamos con resultados de diversos estudios multicentricos a gran escala con galantamina (GALINT-11 y 18) (126-127), donepezilo (Memory Impairment Study) (110) y rivastigmina (Investigation into Delay to Diagnosis of Alzheimer's Disease with Exelon[R], InDDEx) (128), para comprobar su eficacia a la hora de disminuir la tasa de conversion de DCL en EA.